Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01562301 |
|
Recruitment Status :
Withdrawn
First Posted : March 23, 2012
Last Update Posted : June 8, 2015
|
Sponsor:
M.D. Anderson Cancer Center
Collaborators:
National Cancer Institute (NCI)
Nerium Biotechnology
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | June 2016 |
| Study Completion Date : | No date given |